|05 March, 2019

NMC Health joint venture with Hassana Investment Company

All commercial terms and agreements have been finalised between NMC and Hassana

Prashant Manghat - CEO, NMC Health

Prashant Manghat - CEO, NMC Health

Dubai: NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 18 countries, announces the signing of definitive documents to form a joint venture in healthcare ("JV") with Hassana Investment Company ("Hassana"), the investment arm of the General Organization for Social Insurance ("GOSI") in Saudi Arabia. The General Organization for Social Insurance is one of the largest pension funds in the world by assets under management. It is a government administered pension fund covering private sector employees in Saudi Arabia.

All commercial terms and agreements have been finalised between NMC and Hassana, with both parties working towards customary closing requirements. The JV is formed by NMC's contribution of its five assets in KSA and an additional cash injection at closing, and GOSI's contribution of 38.88% stake in Tadawul-listed National Medical Care Company ("Care") at a price of SAR 54 per share. At the closing of the transaction, NMC will own a 52% stake (through the combination of asset contribution and cash injection) and GOSI will own a 48% stake (through a wholly-owned subsidiary vehicle) in the JV. NMC will have operational control of the JV. 

NMC and GOSI have agreed to a well-defined long-term sustainable growth plan for the JV. Moreover, in addition to building solid operational teams at its facilities in KSA, NMC has also meticulously set up an independent corporate team in the Kingdom. It has appointed highly capable and experienced Country CEO, CFO and respective Heads of Strategy, Business Development and Human Resources and believes that the corporate team in KSA is well positioned to integrate and drive the strong growth envisioned for the JV.

Prasanth Manghat, Chief Executive Officer of NMC Health, commented;

"We are pleased to reach this important milestone in the creation of our JV with GOSI, which sets a clear line of sight to the near-term completion of the transaction. This partnership will allow NMC to significantly increase its pace of expansion in the Kingdom, while simultaneously bringing best practices to the country. The attractive, but underserved Saudi healthcare market offers significant growth opportunities and the JV is uniquely placed to benefit from them."

Saad bin Abdulmohsen Al-Fadly, Chief Executive Officer of Hassana, commented;

"The signing of definitive agreements represents a major step towards the formalization of our partnership with NMC. The combination of Hassana/GOSI as one of the pre-eminent financial institutions in the region and NMC Health, the largest and one of the most successful healthcare operators in the GCC, represents a leap forward in our commitment to invest in the healthcare sector in Saudi Arabia. The new JV is well positioned to capitalize on the market opportunities in Saudi and we look forward to transforming the JV into one of the leading healthcare players in the Kingdom."

-Ends-

Contacts 
FTI Consulting
Shane Dolan                                                              
+971 (0)4 437 2100

About NMC Health
NMC the leading private healthcare operator in the GCC with an international network of hospitals across 18 countries. NMC also ranks as one of the top three in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, NMC has identified the Kingdom of Saudi Arabia (KSA) in particular as a key growth market, where the company has introduced long-term and multi-specialty care services. NMC received over 5.7m patients in 2017. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1.6 billion for the year ended 31 December 2017.

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases